Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation

Breast Cancer Research

Volumn 9, Issue 3, 2007, Pages

  Conway, Kathleen ^a,b   Parrish, Eloise ^b   Edmiston, Sharon N ^b   Tolbert, Dawn ^b   Tse, Chiu Kit ^a   Moorman, Patricia ^c   Newman, Beth ^d   Millikan, Robert C ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENARCHE; ORAL CONTRACEPTION; POINT MUTATION; POPULATION BASED CASE CONTROL STUDY; PREMENOPAUSE; RACE DIFFERENCE; RISK FACTOR; SMOKING; UNITED STATES; AMINO ACID SUBSTITUTION; BREAST TUMOR; CAUCASIAN; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; FAMILY; GENETICS; HYPERPLASIA; MIDDLE AGED; MUTATION; NEGRO; PARASITOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; HUMANS; HYPERPLASIA; MENARCHE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34548570830     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1731     Document Type: Article

References (58)

1. Pike MC Spicer DV Dahmoush L Press MF Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 1993, 15:17-35. 8405201
2. Murphy LC Dotzlaw H Leygue E Douglas D Coutts A Watson PH Estrogen receptor variants and mutations J Steroid Biochem Molec Biol 1997, 62:363-372. 10.1016/S0960-0760(97)00084-8 9449239
3. Herynk MH Fuqua SA Estrogen receptor mutations in human disease Endocr Rev 2004, 25:869-898. 10.1210/er.2003-0010 15583021
4. Dotzlaw H Leygue E Watson PH Murphy LC Expression of estrogen receptor-beta in human breast tumors J Clin Endocrinol Metab 1997, 82:2371-2374. 10.1210/jc.82.7.2371 9215322
5. Enmark E Pelto-Huikko M Grandien K Lagercrantz S Lagercrantz J Fried G Nordenskjold M Gustafsson JA Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern J Clin Endocrinol Metab 1997, 82:4258-4265. 10.1210/jc.82.12.4258 9398750
6. Hu YF Lau KM Ho S-M Russo J Increased expression of estrogen receptor in chemically transformed human breast epithelial cells Int J Oncol 1998, 12:1225-1228. 9592178
7. Iwao K Miyoshi Y Egawa C Ikeda N Noguchi S Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancer Int J Cancer 2000, 88:733-736. 10.1002/ 1097-0215(20001201)88:5<733::AID-IJC8>3.0.CO;2-M 11072241
8. Henderson BE Feigelson HS Hormonal carcinogenesis Carcinogenesis 2000, 21:427-433. 10.1093/carcin/21.3.427 10688862
9. Fuqua SA Wiltschke C Zhang QX Borg A Castles CG Friedrichs WE Hopp T Hilsenbeck S Mohsin S O'Connell P A hypersensitive estrogen receptor-α mutation in premalignant breast lesions Cancer Res 2000, 60:4026-4029. 10945602
10. Zubairy S Cui Y Fuqua SA The K303R estrogen receptor alpha breast cancer mutant generates a new Akt kinase site Proc Am Assoc Cancer Res 2004, 45:659.
11. Cui Y Zhang M Pestell R Curran EM Welshons WV Fuqua SAW Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity Cancer Res 2004, 64:9199-9208. 10.1158/ 0008-5472.CAN-04-2126 15604293
12. Conway K Parrish E Edmiston SN Tolbert D Tse J Geradts J Livasy C Singh H Newman B Millikan RC The estrogen receptor alpha A908G (K303R) mutation occurs at low frequency in invasive breast tumors: Results of a population-based study Breast Cancer Res 2005, 7:R871-880. 1410768 16280033 10.1186/bcr1315
13. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Molecular portraits of human breast tumors Nature 2000, 406:747-752. 10.1038/35021093 10963602
14. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 2001, 98:10869-10874. 58566 11553815 10.1073/ pnas.191367098
15. Newman B Moorman P Millikan R Qaqish BF Geradts J Aldrich TE Liu ET The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology Breast Cancer Res Treat 1995, 35:51-60. 10.1007/ BF00694745 7612904
16. Dressler LG Geradts J Burroughs M Cowan D Millikan RC Newman B Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: The UNC SPORE experience Breast Cancer Res Treat 1999, 58:31-39. 10.1023/A:1006354627669 10634516
17. Huang WY Newman B Millikan RC Schell MJ Hulka BS Moorman PG Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status Am J Epidemiol 2000, 151:703-714. 10752798
18. Rouzier R Perou CM Symmans WF Ibrahim N Cristofanilli M Anderson K Hess KR Stec J Ayers M Wagner P Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 2005, 11:5678-5685. 10.1158/1078-0432.CCR-04-2421 16115903
19. Huang E Cheng SH Dressman H Pittman J Tsou MH Horng CF Bild A Iversen ES Liao M Chen CM Gene expression predictors of breast cancer outcomes Lancet 2003, 361:1590-1596. 10.1016/S0140-6736(03)13308-9 12747878
20. Carey LA Perou CM Livasy CA Dressler LG Cowan D Conway K Karaca G Troester MA Tse CK Edmiston S Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 2006, 295:2492-2502. 10.1001/ jama.295.21.2492 16757721
21. Oh DS Troester MA Usary J Hu Z He X Fan C Wu J Carey LA Perou CM Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers J Clin Oncol 2006, 24:1656-1664. 10.1200/JCO.2005.03.2755 16505416
22. Conway K Edmiston SN Cui L Drouin SS Pang J He M Tse CK Geradts J Dressler L Liu ET Prevalence and spectrum of p53 mutations associated with smoking in breast cancer Cancer Res 2002, 62:1987-1995. 11929815
23. Furberg H Millikan RC Geradts J Gammon MD Dressler LG Ambrosone CB Newman B Reproductive factors in relation to breast cancer characterized by p53 protein expression Cancer Causes Control 2003, 14:609-618. 10.1023/A:1025682410937 14575358
24. Terry MB Gammon MD Schoenberg JB Brinton LA Arber N Hibshoosh H Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women Cancer Epidemiol Biomarkers Prev 2002, 11:1100-1103. 12376514
25. Tsakountakis N Sanidas E Stathopoulos E Kafousi M Anogiannaki N Georgoulias V Tsiftsis DD Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status BMC Womens Health 2005, 5:1-9. 549187 15694000 10.1186/ 1472-6874-5-1
26. Potter JD Cerhan JR Sellers TA McGovern PG Drinkard C Kushi LR Folsom AR Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995, 4:319-326. 7655325
27. Althuis MD Brogan DR Coates RJ Daling JR Gammon MD Malone KE Schoenberg JB Brinton LA Breast cancers among very young premenopausal women Cancer Causes Control 2003, 14:151-160. 10.1023/A:1023006000760 12749720
28. Althuis MD Brogan DR Coates RJ Daling JR Gammon MD Malone KE Schoenberg JB Brinton LA Hormonal content and potency of oral contraceptives and breast cancer risk among young women Br J Cancer 2003, 88:50-57. 10.1038/ sj.bjc.6600691 12556959
29. Brinton LA Gammon MD Malone KE Schoenberg JB Dalin JR Coates RJ Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women Contraception 1997, 55:197-203. 10.1016/S0010-7824(97)00012-7 9179450
30. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies Lancet 1996, 347:1713-1727. 10.1016/S0140-6736(96)90806-5 8656904
31. Moorman PG Millikan RC Newman B Oral contraceptives and breast cancer among African-American women and white women J Natl Med Assoc 2001, 93:329-334. 11560288
32. Kumle M Weiderpass E Braaten T Persson I Adami H-O Lund E Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study Cancer Epidemiol Biomarkers Prev 2002, 11:1375-1381. 12433714
33. Dumeaux V Alsaker E Lund E Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study Int J Cancer 2003, 105:844-850. 10.1002/ijc.11167 12767072
34. Wingo PA Lee NC Ory HW Beral V Peterson HB Rhodes P Age-specific differences in the relationship between oral contraceptive use and breast cancer Obstet Gynecol 1991, 78:161-170. 2067757
35. Ursin G Ross RK Sullivan-Halley J Hanisch R Henderson B Bernstein L Use of oral contraceptives and risk of breast cancer in young women Breast Cancer Res Treat 1998, 50:175-184. 10.1023/A:1006037823178 9822222
36. Grabrick DM Hartmann LC Cerhan JR Vierkant RA Therneau TM Vachon CM Olson JE Couch FJ Anderson KE Pankratz VS Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer JAMA 2000, 284:1791-1798. 10.1001/jama.284.14.1791 11025831
37. Narod SA Dube MP Klijn J Lubinski J Lynch HT Ghadirian P Provencher D Heimdal K Moller P Robson M Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 2002, 94:1773-1779. 12464649
38. Milne RL Knight JA John EM Dite GS Balnuena R Ziogas A Andrulis IL West DW Li FP Southey MC for the Breast Cancer Family Registry Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRC1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev 2005, 14:350-356. 10.1158/1055-9965.EPI-04-0376 15734957
39. Jernstrom H Loman N Johannsson OT Borg A Olsson H Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing Eur J Cancer 2005, 41:2312-2320. 10.1016/j.ejca.2005.03.035 16118051
40. Fowke JH Shu X-O Dai Q Jin F Cai Q Gao Y-T Zheng W Oral contraceptive use and breast cancQr risk: Modification by NAD(P)H: quinone oxoreductase (NQO1) genetic polymorphisms Cancer Epidemiol Biomarkers Prev 2004, 13:1308-1315. 15298951
41. Newcomer LM Newcomb PA Trentham-Dietz A Longnecker MP Greenberg ER Oral contraceptive use and risk of breast cancer by histologic type Int J Cancer 2003, 106:961-964. 10.1002/ijc.11307 12918077
42. Li CI Malone KE Porter PL Weiss NS Tang MT Daling JR Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age Int J Cancer 2003, 107:647-651. 10.1002/ijc.11465 14520705
43. Li CI Malone KE Porter PL Weiss NS Tang M-TC Cushing-Haugen KL Daling JR Relationship between long durations and different regimens of hormone therapy and risk of breast cancer JAMA 2003, 289:3254-3263. 10.1001/ jama.289.24.3254 12824206
44. Chen C-L Weiss NS Newcomb P Barlow W White E Hormone replacement therapy in relation to breast cancer JAMA 2002, 287:734-741. 10.1001/ jama.287.6.734 11851540
45. Isaksson E von Schoultz E Odlind V Soderqvist G Csemiczky G Carlstrom K Skoog L von Schoultz B Effects of oral contraceptives on breast epithelial proliferation Breast Cancer Res Treat 2001, 65:163-169. 10.1023/A:1006482418082 11261832
46. Olsson H Jernstrom H Alm P Kreipe H Ingvar C Jonsson PE Ryden S Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use and reproductive factors Breast Cancer Res Treat 1996, 40:187-196. 10.1007/BF01806214 8879685
47. Anderson E Clarke RB Howell A Estrogen responsiveness and control of normal human breast proliferation J Mammary Gland Biol Neoplasia 1998, 3:23-35. 10.1023/A:1018718117113 10819502
48. Williams G Anderson E Howell A Watson R Coyne J Roberts SA Potten CS Oral contraceptive (OCP) use increases proliferation and decreases oestrogen content of epithelial cells in the normal human breast Int J Cancer 1991, 48:206-210. 10.1002/ijc.2910480209 2019467
49. Laidlaw IJ Clarke RB Howell A Owen AW Potten CS Anderson E The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone Endocrinology 1995, 136:164-171. 10.1210/en.136.1.164 7828527
50. Bramley M Clarke RB Howell A Evans DGR Armer T Baildam AD Anderson E Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations Br J Cancer 2006, 94:1021-1028. 10.1038/sj.bjc.6603042 16538216
51. Dupont W Page D Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 1985, 312:146-151. 3965932
52. O'Connell P Pekkel V Fuqua SAW Osborne CK Clark GM Allred DC Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci J Natl Cancer Inst 1998, 90:697-703. 10.1093/jnci/90.9.697 9586667
53. Lakhani SR Slack DN Hamoudi RA Collins N Stratton MR Sloane JP Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations Lab Invest 1996, 74:129-135. 8569175
54. Chlebowski and The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial JAMA 2004, 291:1701-1712. 10.1001/jama.291.14.1701 15082697
55. Hofseth LJ Raafat AM Osuch JR Pathak DR Slomski CA Haslam SZ Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J Clin Endocrinol Metab 1999, 84:4559-4565. 10.1210/jc.84.12.4559 10599719
56. Moorman PG Kuwabara H Millikan RC Newman B Menopausal hormones and breast cancer in a biracial population Am J Public Health 2000, 90:966-971. 1446270 10846517
57. Newman B Mu H Butler LM Millikan RC Moorman PG King MC Frequency of breast cancer attributable to BRCA1 in a population-based series of American women JAMA 1998, 279:915-921. 10.1001/jama.279.12.915 9544765
58. Silvera SA Miller AB Rohan TE Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: A prospective cohort study Cancer Causes Control 2005, 16:1059-1063. 10.1007/ s10552-005-0343-1 16184471